全文获取类型
收费全文 | 1486068篇 |
免费 | 105873篇 |
国内免费 | 2891篇 |
专业分类
耳鼻咽喉 | 20451篇 |
儿科学 | 47692篇 |
妇产科学 | 41672篇 |
基础医学 | 213170篇 |
口腔科学 | 39325篇 |
临床医学 | 129780篇 |
内科学 | 294924篇 |
皮肤病学 | 29438篇 |
神经病学 | 120353篇 |
特种医学 | 59091篇 |
外国民族医学 | 379篇 |
外科学 | 229889篇 |
综合类 | 28794篇 |
现状与发展 | 2篇 |
一般理论 | 467篇 |
预防医学 | 107741篇 |
眼科学 | 34116篇 |
药学 | 111730篇 |
2篇 | |
中国医学 | 2789篇 |
肿瘤学 | 83027篇 |
出版年
2021年 | 12101篇 |
2019年 | 12491篇 |
2018年 | 17219篇 |
2017年 | 12860篇 |
2016年 | 14373篇 |
2015年 | 16667篇 |
2014年 | 23394篇 |
2013年 | 34451篇 |
2012年 | 48822篇 |
2011年 | 51819篇 |
2010年 | 30156篇 |
2009年 | 28363篇 |
2008年 | 49078篇 |
2007年 | 52760篇 |
2006年 | 52920篇 |
2005年 | 52104篇 |
2004年 | 49892篇 |
2003年 | 47628篇 |
2002年 | 46690篇 |
2001年 | 59822篇 |
2000年 | 60855篇 |
1999年 | 52455篇 |
1998年 | 16707篇 |
1997年 | 14768篇 |
1996年 | 14812篇 |
1995年 | 13904篇 |
1994年 | 13144篇 |
1993年 | 12211篇 |
1992年 | 41869篇 |
1991年 | 41177篇 |
1990年 | 40589篇 |
1989年 | 39376篇 |
1988年 | 36711篇 |
1987年 | 35910篇 |
1986年 | 34301篇 |
1985年 | 32768篇 |
1984年 | 24742篇 |
1983年 | 21536篇 |
1982年 | 13308篇 |
1979年 | 23062篇 |
1978年 | 16354篇 |
1977年 | 14134篇 |
1976年 | 13354篇 |
1975年 | 14487篇 |
1974年 | 16969篇 |
1973年 | 16303篇 |
1972年 | 15477篇 |
1971年 | 14373篇 |
1970年 | 13310篇 |
1969年 | 12807篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
31.
32.
Hideki Kawaguchi Kazuko Masuo Tomohiro Katsuya Ken Sugimoto Hiromi Rakugi Toshio Ogihara Michael L Tuck 《Hypertension research》2006,29(12):951-959
High blood pressure (BP) is a major determinant of cardiovascular events in obesity. The beta2- and beta3-adrenoceptor polymorphisms are associated with obesity and hypertension. In the present study, we examine the relationships of beta2- and beta3-adrenoceptor polymorphisms with further weight gain-induced BP elevation in obese subjects. Changes in BP, body weight, total body fat-mass, waist-to-hip ratio, plasma norepinephrine (NE) and leptin levels, and beta2(Arg16Gly)- and beta3(Trp64Arg)-adrenoceptor polymorphisms were measured periodically over a 5-year period in 55 entry obese (body mass index [BMI]> or =25.0 kg/m(2)) normotensive (BP<140/90 mmHg) men. BP elevation and weight gain were defined as > or =10% increases from entry levels over 5 years in mean BP or BMI. Obese subjects with weight gain, BP elevation or weight gain-induced BP elevation had higher frequencies of the Gly16 allele of Arg16GIy and Arg64 allele of Trp64Arg. Subjects carrying the Gly16 or Arg64 alleles had significantly greater total fat-mass and waist-to-hip ratio at entry and over a 5-year period compared to the subjects who did not carry these polymorphisms. Subjects carrying the Gly16 allele had similar levels of plasma NE, higher levels of plasma leptin and a lower slope of the regression lines between plasma leptin and NE levels. Those carrying the Arg64 allele had higher plasma NE levels at entry and over a 5-year period compared to the subjects without the Arg64 allele, but plasma leptin levels and slopes were similar. The findings demonstrate that the Arg64 allele of the beta3-adrenoceptor polymorphisms relates to weight gain-induced BP elevation accompanying high plasma NE (heightened sympathetic activity) in obese men. The Gly16 allele of the beta2-adrenoceptor polymorphisms links to weight gain-induced BP elevation associated with leptin resistance. beta2- and beta3-adrenoceptor polymorphisms could predict the future BP elevation and further weight gain-induced BP elevation in originally obese subjects. 相似文献
33.
There is some evidence suggesting that Parkinson's disease (PD) patients exhibit lower body weight when compared to age-matched healthy subjects. Low body mass index (BMI) is correlated with low bone mineral density, both of which are major risk factors for hip fractures. Possible determinants of weight loss in PD patients include hyposmia, impaired hand-mouth coordination, difficulty chewing, dysphagia, intestinal hypomotility, depression, decreased reward processing of dopaminergic mesolimbic regions, nausea, and anorexia as the side effects of medication, and increased energy requirements due to muscular rigidity and involuntary movements. It is unclear whether PD patients in general, or only a subgroup of those affected, definitely show lower BMI in the advanced stages of the disease. We therefore recommend that the body weight of PD patients be monitored monthly as the disease progresses, and that a patient's nutrition should be supplemented with sufficient amounts of vitamin D and calcium to reduce the risk of hip fractures and strengthen bone density. Because meal times may coincide with unpredictable off periods associated with akinesia and impaired hand-mouth coordination, PD patients also need flexible food schedules that accommodate the associated symptoms of this disease. 相似文献
34.
35.
36.
37.
38.
K M Sarraf M Abdalla O Al-Omari M G Sarraf 《Ultrasound in obstetrics & gynecology》2006,27(2):220-221
We report the case of a 38-year-old woman who presented with chronic lower abdominal pain. Her past medical history included a splenectomy due to abdominal trauma. Ultrasound examination revealed four pelvic tumors which, upon laparotomy, were found to be the result of splenosis. Approximately 100 cases of splenosis have been reported but only a minority of them have been published in the gynecological literature. Our case indicates that those involved in pelvic scanning (even of asymptomatic women) and/or treating those complaining of lower abdominal pain or presenting with pelvic tumors should be aware of splenosis as a possible diagnosis. 相似文献
39.
40.